Why the study?
To enhance the understanding of identifying personalized pharmacotherapy options in Traditional Chinese Medicine and support the registration of new Traditional Chinese Medicine drugs.
Machine learning algorithms can identify symptom-herb association rules in Traditional Chinese Medicine for patients with resistant hypertension to potentially guide personalized pharmacotherapy.
Answers are grounded in this paper and cite their sources.
May support TCM pattern assessment in MACE patients; hypothesis-generating for ML-guided therapy in resistant hypertension.
OBJECTIVE: To enhance the understanding of identifying personalized pharmacotherapy options in Traditional Chinese Medicine (TCM), and further support the registration of new TCM drugs. METHODS: Generalized Boosted Models and XGBoost were employed to construct a classification model to identify the bad prognosis factors in resistant hypertension (RH) patients. Furthermore, we used association analysis to explore the rules of "symptom-syndrome" and "symptom-herb" for the major influencing factors, in order to summarize prescription pattern and applicable patients of TCM. RESULTS: Patients with major adverse cardiac events mostly have complex symptoms of phlegm, stasis, deficiency and fire intermingled with each other, and finally summarized the human experience of using Chinese herbal medicine to precisely intervene in some symptoms of RH patients on the basis of conventional Western medical treatment. CONCLUSIONS: Machine learning algorithms can make full use of human use experience and evidence to save clinical trial resources and accelerate the development of TCM varieties.
No takes yet. Share an insight, caveat, or question.
Qianzi et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: